Text Size
44 studies found for:    " March 16, 2011":" April 15, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" March 16, 2011":" April 15, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Project RAP: Family-based HIV Prevention in the Juvenile Drug Court
Condition: HIV/AIDS
Interventions: Behavioral: Family-Based HIV prevention;   Other: Adolescent Only Health Promotion
2 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
3 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
4 Recruiting Enhancement of Connect to Protect® (C2P)
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
5 Unknown † Improving Antiretroviral Medication Adherence Among HIV-infected Youth
Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
6 Completed
Has Results 		Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
7 Completed Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
Condition: HIV Infection
Intervention:
8 Active, not recruiting Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen
Conditions: Hepatitis C, Chronic;   HIV Infection
Interventions: Drug: Telaprevir;   Biological: pegIFN alfa-2a;   Drug: Ribavirin
9 Recruiting Dating Violence and HIV Prevention in Girls: Adapting Mental Health Interventions
Conditions: Dating Violence;   HIV Infections
Interventions: Behavioral: Cognitive-Behavioral Dating Violence and HIV Prevention Group;   Behavioral: Psycho-educational Dating Violence and HIV prevention group
10 Active, not recruiting Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: empowerment theory-based small group discussion;   Behavioral: individual resilience counseling
11 Active, not recruiting The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C;   HIV and Hepatitis C Coinfection
Intervention:
12 Recruiting The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
Condition: HIV-1 Infection
Intervention: Drug: Vorinostat
13 Active, not recruiting Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
Conditions: HCV Coinfection;   HIV-1 Infection
Intervention: Drug: Boceprevir, Peg-interferon alfa 2b and Ribavirin
14 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
15 Completed EuroSIDA As An External Comparator To MOTIVATE Trials
Conditions: HIV;   AIDS
Intervention: Other: maraviroc
16 Recruiting Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
17 Active, not recruiting Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Condition: Human Immunodeficiency Virus Infection
Intervention:
18 Recruiting Microparticles, Vector of Genetic Information During HIV Infection
Condition: HIV,
Intervention: Biological: Blood samples
19 Completed Role of HIV on Glutathione Synthesis and Oxidative Stress
Conditions: HIV Infection;   Erythrocyte Glutathione Deficiency
Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and glycine;   Dietary Supplement: Cysteine/glycine
20 Recruiting Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Grade I Lymphomatoid Granulomatosis;   Recurrent Grade II Lymphomatoid Granulomatosis;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Multiple Myeloma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bendamustine hydrochloride;   Drug: veliparib;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Biological: rituximab
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years